echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Another benefit of losing weight!

    Another benefit of losing weight!

    • Last Update: 2022-01-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Yimaitong compiles and organizes, please do not reprint without authorization
    .

    Introduction: Recently, a study published in the journal JAMA Surgery showed that obese patients who have lost a lot of weight after undergoing metabolic surgery have a significantly lower risk of serious complications of COVID-19
    .

    Study Overview Participants from the same center in the United States, the number of nearly 12,000, during the median follow-up period of the past 8 years, the weight of obese patients undergoing metabolic surgery was reduced by an average of nearly 19% compared with control obese patients who did not undergo surgery
    .

    During the 12-month period from March 1, 2020 to March 1, 2021, the researchers evaluated the COVID-19 status of 2,958 surgical group and 8,851 control participants
    .

    During the period, 206 participants in the surgery group and 578 participants in the control group were infected with COVID-19.
    At the time of the positive diagnosis, the average weight of the participants in the surgery group was 108.
    4 kg and the control group was 128.
    4 kg
    .

     Although the infection rate is similar, the risk of severe illness is significantly reduced.
    The results of the study show that the incidence of COVID-19 in the operation group and the control group is roughly the same.
    The infection rate in both groups from March 2020 to March 2021 is about 9%
    .

     However, in the surgery group, the risk of hospitalization was reduced by 49%, the risk of additional oxygen was reduced by 63%, and the risk of severe COVID-19 was reduced by 60%
    .

    In addition, the all-cause mortality in the surgery group was reduced by 73%, although this difference was not significant (P=0.
    09)
    .

     Obesity is a "changeable risk factor" for severe COVID-19.
    Some scholars said that it is usually difficult to design a special team-controlled trial for severely obese patients to evaluate the results of new coronary pneumonia after weight loss intervention
    .

    The data of this study provides good evidence that substantial and sustained weight loss can reduce the risk of severe COVID-19 in infected obese people
    .

    Although the risk of infection is the same, among those who have undergone metabolic surgery and subsequent weight loss, the incidence of complications is much lower
    .

     References: Aminian A, Tu C, Milinovich A, Wolski KE, Kattan MW, Nissen SE.
    Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection Published.
    JAMA Surg.
    online December 29, 2021.
    doi :10.
    1001/jamasurg.
    2021.
    6496
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.